Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals
Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals
預測未來：11位分析師對Crinetics藥品的預測
Throughout the last three months, 11 analysts have evaluated Crinetics Pharmaceuticals (NASDAQ:CRNX), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，11位分析師評估了Crinetics藥品（納斯達克：CRNX），提出了從看好到看淡的多樣化意見。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $69.82, a high estimate of $97.00, and a low estimate of $60.00. This current average has increased by 13.27% from the previous average price target of $61.64.
由分析師分析的12個月價格目標提供了一些見解，平均目標爲69.82美元，最高估計達到97.00美元，最低估計爲60.00美元。這個當前平均值比上一個61.64美元的平均價格目標增長了13.27%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
The analysis of recent analyst actions sheds light on the perception of Crinetics Pharmaceuticals...
最近的分析師行動分析揭示了金...
登入免費觀看全文
登入/註冊